PAI-1 antagonists: the promise and the peril.

Transactions of the American Clinical and Climatological Association

Volumn 122, Issue , 2011, Pages 312-325

  Vaughan, Douglas E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; FEMALE; FIBRINOLYSIS; FIBROSIS; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; THROMBOSIS; TREATMENT OUTCOME;

ANIMALS; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; FIBROSIS; HUMANS; MALE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYCYSTIC OVARY SYNDROME; THROMBOSIS; TREATMENT OUTCOME;

EID: 80053333461     PISSN: 00657778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)